Abstract
Study Design.
Experimental porcine anterior cervical discectomy and fusion (ACDF) model: a proof-of-concept study.
Objective.
The effect of monetite synthetic bone graft (SBG) containing calcium pyrophosphate and β-tricalcium phosphate on cervical spinal fusion in a noninstrumented two-level large animal model.
Summary of Background Data.
ACDF is the gold standard surgical technique for the treatment of degenerative cervical spinal diseases. However, pseudarthrosis associated with increased patient morbidity occurs in ∼2.6% of the surgeries. SBG may enhance bony fusion and subsequently decrease the risk of pseudarthrosis. Recent studies on monetite-based SBGs for use in large cranial defects in humans have shown promising bone healing results, necessitating further investigation of their use in cervical spinal fusion.
Materials and Methods.
Four adult female Danish Göttingen minipigs received partial cervical anterior discectomy and intervertebral defects at an upper and lower level. One defect was filled with SBG, and the other was left empty. Bony fusion was evaluated using computed tomography (CT) at three-month intervals for 12 months. Fifteen months postsurgery, the animals were euthanized for further ex vivo qualitative histopathologic and micro-CT evaluations. Fusion rates were compared using the Fisher exact test at each time point.
Results.
Increased interbody bony fusion rates were observed at SBG levels (4/4) compared with control levels (0/4) evaluated by CT at 6 and 9 months postsurgery (P=0.029). Fusion was observed at all SBG levels 12 months postsurgery and at only one control level. Histopathologic evaluation confirmed high-quality interbody bony fusion at all SBG levels and fusion by spondylosis at one control level.
Conclusion.
This proof-of-concept study provides preliminary evidence of a novel, calcium pyrophosphate-containing, and β-tricalcium phosphate-containing monetite SBG that promotes bony fusion compared with a negative control in a clinically relevant porcine model of ACDF.
Key words: anterior cervical fusion, pseudarthrosis, interbody fusion, pig, bone, synthetic bone graft, monetite, calcium pyrophosphate, computed tomography, micro-CT, histopathology
Degenerative cervical spine disease is a global health concern and is associated with a substantial socioeconomic burden and patient morbidity.1,2 To treat degenerative cervical conditions, anterior cervical discectomy and fusion (ACDF) is the gold standard surgical technique.3–5 In the United States, anterior fusion procedures accounted for 80.6% of all cervical spine surgeries from 2001 to 2013, and around 127,500 ACDF surgeries were performed in 2013. ACDF is considered one of the most costly surgical procedures in the United States, accounting for a total of 2.152 billion yearly in aggregated costs.6 This procedure typically results in excellent clinical outcomes. However, in 2.6% of the surgeries, failure of interbody bony union results in pseudarthrosis.7 This outcome is associated with increased patient morbidity, for example, persistent neck pain, instability, radiculopathy, myelopathy8 and is a leading cause of revision surgery associated with poorer quality of life.9 Reoperating rates have been reported to range between 0.58% and 11.1% depending on the number of levels involved.10–13 Autologous bone grafting (ABG) is used to assist bony fusion and thereby avoid pseudarthrosis.14 Synthetic alternatives, such as calcium phosphate-based grafts (CaPBGs), are often used instead of ABG. In comparison, they are simple to use and decrease surgery time and unnecessary donor site morbidity.15–17 Several CaPBGs have excellent osteoconductive and degradation properties, as well as biocompatibility.18,19 Some recently developed multicomponent CaPBGs have shown osteoinductive behavior ascribed to incorporating different phases of calcium phosphate (CaP), such as monetite, or both beta-tricalcium phosphate (β-TCP) and calcium pyrophosphate (Ca-PP).20–23 Recent studies on a monetite-based synthetic bone graft (SBG) have shown promising bone healing results in the treatment of large cranial defects in humans.24–27 The present proof-of-concept study, therefore, aimed to evaluate a novel Ca-PP-containing and β-TCP-containing monetite SBG in comparison to control level surgery in a noninstrumented two-level ACDF porcine model. It was hypothesized that SBG would promote interbody cervical spinal fusion in comparison with the negative control level in this clinically relevant porcine model of ACDF.
MATERIALS AND METHODS
Study Design and Animal Model
The proof-of-concept study was approved by the Animal Ethics Board in Uppsala, Sweden (protocol:08751-2019) and conducted under Good Laboratory Practices at the University of Agricultural Sciences in Uppsala, Sweden, between November 2019 and February 2021 in accordance with the Swedish National Guidelines for the Care and Use of Laboratory Animals.28 Four separately housed adult female Danish Göttingen minipigs (N4; Ellegaard Göttingen Minipigs, Denmark; see Table, Supplemental Digital Content 1, http://links.lww.com/BRS/C369, experimental animals) received anterior partial discectomy and intervertebral defect at an upper and lower level of the cervical vertebral column. One defect was randomly allocated to be filled with SBG, whereas the other defect was left empty as an internal negative control. The primary outcome was bony fusion, evaluated using computed tomography (CT) every three months, over 12 months. Secondary imaging outcomes were evaluated at the same time intervals. Fifteen months postsurgery, the animals were euthanized (Table, SDC2, euthanasia, Supplemental Digital Content 2, http://links.lww.com/BRS/C370) for further ex vivo qualitative histopathologic and μCT evaluations.
Preparation of SBG
Dicalcium phosphate dihydrate was prepared from a mixture of the two precursors. The first precursor consisted of β-TCP containing 10 wt% β-calcium pyrophosphate (β-CPP) synthesized as described below, whereas the second precursor consisted of monocalcium phosphate monohydrate (MCPM, Scharlau) sieved below 75 μm, mixed at a β-TCP:MCPM molar ratio of 1:0.818, and then mixed with water at a ratio of 0.22 mL/g. Specimens were injected into molds, allowed to react for 24 hours, and then sterilized by autoclaving at 121°C for 40 minutes and the following material composition was yielded: 1% dicalcium phosphate dihydrate, 9% β-CPP, 6% β-TCP, 1% MCPM, and 83% dicalcium phosphate anhydrous, as determined from X-ray diffraction and Rietveld refinement.
Surgical Procedure
In short, using an anterior median approach to the cervical spine, intervertebral spaces were exposed at an upper level of C2/3 or C3/4 and a lower level of C4/5 or C5/6 with an intermediate level left intact. Two defects, ranging between ∼172 and 945 mm3, were created for each animal by resecting parts of the anterior aspect of the exposed disc tissue, end plates, and vertebral bodies, with the dorsal longitudinal ligament remaining intact. Thereafter, the defects were filled with SBG, morselized using forceps, or left empty. No vertebral fixation was used. Routine closure was performed. Surgeries were performed under general anesthesia with perioperative and postoperative analgesia (Table, SDC2, anesthesia and analgesia, Supplemental Digital Content 2, http://links.lww.com/BRS/C370) by the same board-certified veterinary surgeon, intending to create a similar defect size at each operated level. The animals were monitored continuously for seven days postsurgery using video surveillance as part of another study.
Computed Tomography
The cervical spine was scanned at an isotropic resolution of 0.6 mm (Somatom Definition AS 64; Siemens, The Netherlands). CT 3D multiplane reconstruction was performed with 0.6 mm slice thickness and a B70s kernel of the spine helical series with a voxel size of ∼0.25×0.25×0.6 mm. CT analysis was performed according to a protocol (Figure, SDC 1-5, CT protocols, Supplemental Digital Content 3, http://links.lww.com/BRS/C371, Supplemental Digital Content 4, http://links.lww.com/BRS/C372, Supplemental Digital Content 5, http://links.lww.com/BRS/C373, Supplemental Digital Content 6, http://links.lww.com/BRS/C374, Supplemental Digital Content 7, http://links.lww.com/BRS/C375) prepared by a board-certified veterinary radiologist and analyzed in a nonblinded manner by a supervised veterinary imaging resident. Fusion was evaluated as interbody bony fusion (IBF) and fusion by spondylosis (FbS), defined as any continuous trabecular bony bridge within the disc space or outside the disc space, respectively. Fusion was classified binary as “fused” or “nonfused.” Intervertebral disc space was measured at four different anatomical locations: anterior, posterior, right, and left at the midsagittal section and normalized to baseline intervertebral disc space. The degree of sclerosis, vertebral body lysis, and bone formation within the disc space were also recorded. To estimate the amount of anterior bone formation, the spondylosis anteroposterior dimension ratio (Rab) was calculated. Horos software (Nimble Co LLC d/b/a Purview Annapolis, MD, USA) was used for image analysis and processing.29
Microcomputed tomography
After euthanasia of the animals 15 months postsurgery, the cervical vertebrae were examined with micro-CT (μCT; SkyScan 1176, Kontich, Belgium) at 90 kV voltage and 278 µA current, using a 0.1 mm Cu filter and 360° scan with a voxel size of 9 μm, ∼80x the resolution of traditional CT. Images were reconstructed with NRecon and visualized using the CTVox software (SkyScan; Bruker MicroCT). Fusion was evaluated at the control and SBG levels using the same definition as that used for CT evaluation.
Histopathology
Necropsy was performed on all animals, and routine histology of tissues from the heart, lung, liver, kidney, and fundus of the ventricle was performed. The tissue was fixed in 10% phosphate-buffered formalin, stained with hematoxylin and eosin (kidney sections were also stained with van Gieson’s), and examined under a light microscope for histopathologic lesions according to standard procedures. Following μCT, undecalcified histologic processing was performed on vertebral column specimens. Vertebral columns were fixed in 10% phosphate-buffered formalin for seven days and stored in 70% ethanol for approximately seven months at room temperature until they were processed for histopathology. Segments were cut using an oscillating saw in the sagittal plane. Each specimen was then dehydrated in graded solutions of alcohol and infiltrated with increasing concentrations of polymethylmethacrylate (Technovit 7200 Kulzer GmbH, Hanau, Germany) mixed with 99.9% ethanol before being polymerized into hardened polymethylmethacrylate blocks. Sections were produced in the sagittal plane at a thickness ranging between 16 and 64 µm and stained with modified paragon stain for histopathologic examination. The left, central, and right sagittal sections were examined under a light microscope and imaged using a microscope camera. Fusion was evaluated in all sections, and the local tissue response to the material was scored semiquantitatively (Table, SDC3, scoring scheme, Supplemental Digital Content 8, http://links.lww.com/BRS/C376) according to the International Organization of Standardization (10993-6:2016)30 by a nonblinded, experienced veterinary pathologist.
Statistical Analyses
Statistical analyses were performed on all outcome parameters using GraphPad Prism version 9 (Boston, Massachusetts, USA). The median values with the minimum and maximum values are presented (range). Fusion rates were compared using the Fisher exact test for each timepoint; intervertebral disc space and Rab using multiple Wilcoxon tests corrected for multiple comparisons. Statistical significance was set at P<0.05.
RESULTS
No intraoperative or major postoperative complications were noted. Necropsy revealed no major pathology (Figure, SDC6, summary of the necropsy, Supplemental Digital Content 9, http://links.lww.com/BRS/C377).
Computed Tomography
Increased IBF rates were observed at SBG levels compared with negative control levels at six and nine months postsurgery (Table 1 and Fig. 1; 4/4 SBG, 0/4 control; P=0.029). All SBG levels (4/4) were also fused by IBF at 12 months postsurgery in comparison with one control level (1/4). In contrast, no difference in fusion rate was observed when FbS was evaluated between the SBG and control levels (Table 2). All the pigs had a radiographically normal cervical vertebral column before surgery.
TABLE 1.
Interbody Bony Fusion Rate
The number of levels, out of the total number of levels operated for the control and synthetic bone graft (SBG) groups, was evaluated by computed tomography as interbody bony fusion during the 12-month study period. Fusion rates were compared using the Fisher exact test for each timepoint.
P=0.029.
Statistical significance was set at P<0.05.
Figure 1.

Chronological computed tomography images of a representative control and synthetic bone graft level. Midsagittal computed tomography images of synthetic bone graft (SBG) and control level of a representative animal over the study period. Fusion was evaluated through the entire intervertebral disc space as interbody bony fusion and fusion by spondylosis, defined as any continuous trabecular bony bridge within the disc space or outside the disc space, respectively. Interbody bony fusion was observed at three, six, nine, and 12 months postsurgery and fusion by spondylosis fusion by spondylosis at nine and 12 months for this animal. A indicates anterior; M, months postsurgery; P, posterior; postop, postoperative.
TABLE 2.
Fusion by Spondylosis Rate
| 3 mo | 6 mo | 9 mo | 12 mo | |
|---|---|---|---|---|
| SBG fusion rate | 1/4 | 2/4 | 4/4 | 4/4 |
| Control fusion rate | 0/4 | 0/4 | 1/4 | 1/4 |
Number of levels, out of the total number of levels operated for the control and synthetic bone graft (SBG) group, was evaluated by computed tomography as fusion by spondylosis during the 12-month study period. Fusion rates were compared using the Fisher exact test for each timepoint.
SBG indicates synthetic bone graft.
Statistical significance was set at P<0.05.
Secondary CT results showed that the median total intervertebral disc space tended to decrease at SBG levels compared with that at control levels at nine and 12 months postsurgery (Fig. 2). Disc space did not tend to differ between levels before surgery and at unoperated disc levels over the 12-month study period (Fig. 2). Variable degrees of vertebral body sclerosis, lysis (low grades: Grade I–II, 1%–25%, and 26%–50%), and bone formation were detected at all time points during the study period (Table, SDC 4, Supplemental Digital Content 10, http://links.lww.com/BRS/C378; 5, Supplemental Digital Content 11, http://links.lww.com/BRS/C379; and 6, Supplemental Digital Content 12, http://links.lww.com/BRS/C380, vertebral body sclerosis, lysis, and bone formation). No differences were observed in Rab between the SBG and control levels at any timepoint during the study period (Table 3).
Figure 2.

Median total intervertebral disc space. Median total (tot.) intervertebral disc space (mm) for all levels of the cervical spine was calculated as the sum of the minimum anterior, posterior, right, and left intervertebral disc spaces and normalized to baseline disc space for each level of the cervical spine at each timepoint (postop disc space—preop disc space). The error bars indicate the range. Multiple Wilcoxon tests corrected for multiple comparisons were used to compare the groups. C indicates cervical vertebral number; M, months postsurgery; N, number of animals; postop, postoperative; preop, preoperative; SBG, synthetic bone graft. Statistical significance was set at P<0.05.
TABLE 3.
Spondylosis Anterioposterior Dimension Ratio
| 3 mo | 6 mo | 9 mo | 12 mo | |
|---|---|---|---|---|
| SBG Rab | 1.11 (0.72–1.45) | 1.34 (1.17–1.55) | 1.33 (1.21–1.48) | 1.32 (1.19–1.45) |
| Control Rab | 1.13 (0.99–1.18) | 1.26 (1.02–1.43) | 1.32 (0.99–1.64) | 1.36 (1.05–1.60) |
Comparison of spondylosis anterioposterior dimension ratio (Rab) calculated as spondylosis anterioposterior dimension 12 months after surgery (a) divided by disc space anterioposterior dimension before surgery (b) for synthetic bone graft (SBG) and control levels. Rab reported as the median (range). Rab was compared by using multiple Wilcoxon test corrected for multiple comparisons.
Statistical significance was set at P<0.05.
Microcomputed tomography
μCT acquisition 15 months postsurgery showed missing data for one of four animals; this animal was excluded from the qualitative μCT evaluation and was the same animal that showed fusion at the control level on CT evaluation. IBF and FbS were observed in all three remaining SBG levels (3/3) and in none of the three control levels (0/3). The SBG fusions were predominantly occupied by trabecular bony bridging, with a clear trabecular pattern (Fig. 3A–F).
Figure 3.

Microcomputed tomography and histopathology of a control and synthetic bone graft specimen. A representative midsagittal section of a control and synthetic bone graft level from the same animal was prepared using microcomputed tomography (μCT; A–F) and histopathology (G–L) 15 months postsurgery. Magnification of histopathologic (I–L) and corresponding μCT sections (C–F). The control group showed fibrous tissue (asterix) and bone islands but no trabecular bony bridging, and the synthetic bone graft level showed synthetic bone graft aggregates (triangle) and trabecular bony (TB) bridging. Histopathology sections were stained with modified paragon stain.
Histopathology
Histopathologic examination at 15 months postsurgery revealed IBF at all SBG levels (4/4) and none of the control levels (0/4). FbS was observed at all SBG levels (4/4) and only at one control level (1/4). SBG was considered to demonstrate minimal or no reaction to the tissue compared with the control, and degradation of SBG ranged from mild to strong (Table 4). Defects at the SBG level were partly filled with mature bone, whereas defects at the control level were filled with either or both fibrous tissue and necrotic material, sometimes mixed with cartilage and mature bone (Fig. 3G–L). The control fusion consisted of irregular trabeculae with active clast-like multinucleated cells, small marrow spaces, and less mature bone, compared with the more mature trabecular bone with only a few foci of immature woven bone in the SBG fusions (Figure, SDC7, Supplemental Digital Content 13, http://links.lww.com/BRS/C381, histology of control fusion). The bone marrow of SBG fusions consisted predominantly of adipose tissue with hematopoietic cells, only at the vertebral body interface. Aggregates of SBG, which were not completely resorbed by 15 months, were embedded in trabecular bone in three of four animals (Figure, SDC8, Supplemental Digital Content 14, http://links.lww.com/BRS/C382, histology of SBG) and appeared to be integrated in bone tissue in the fourth animal (Figure, SDC9, Supplemental Digital Content 15, http://links.lww.com/BRS/C383, histology of SBG). In three of the four animals, foci of macrophages and multinucleated giant cells were observed at the aggregate margins filled with granula resembling SBG material (Figure, SDC10, Supplemental Digital Content 16, http://links.lww.com/BRS/C384 and 11, Supplemental Digital Content 17, http://links.lww.com/BRS/C385, histology of SBG). Focally, osteogenic buds with clast-like cells and osteoblasts appeared to grow toward SBG aggregates (Figure, SDC12, Supplemental Digital Content 18, http://links.lww.com/BRS/C386, histology of SBG). No major inflammatory cell infiltrates or necrotic areas were observed at any of the levels evaluated.
TABLE 4.
Histopathologic Tissue Reaction to Synthetic Bone Graft According to ISO 10992-6:2016
| Cell type/response | SBG level | Control level | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | |
| Polymorphonuclear cells | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Lymphocytes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Plasma cells | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Macrophages | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Giant cells | (3+0+0) | (1+1+0) | (0+2+0) | 0 | 0 | 0 | 0 | 0 |
| Necrosis | 0 | 0 | (1+2+1) | 0 | (3+3+3) | 0 | (1+3+2) | 0 |
| Average subtotal×2 | 2 | 1,3 | 4 | 0 | 6 | 0 | 4 | 0 |
| Neovascularization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fibrosis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fatty infiltrate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Subtotal×1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total tissue response | 2 | 1,3 | 4 | 0 | 6 | 0 | 4 | 0 |
| Group total | 7,3 | 10 | ||||||
| Average* | 1,8 (-) | 2,5=−0,7 | ||||||
| Conclusion | −0,7=0, Minimal or no reaction (0,0 to 2,9) | |||||||
| Traumatic necrosis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Foreign debris (synthetic bone graft) | (3+3+0) | (2-2-0) | (0+3+1) | (0+1+0) | 0 | 0 | 0 | 0 |
| Degradation of synthetic bone graft | (3+3+1) | (3+3+0) | (0+3+3) | (NA+3 +NA) | NA | NA | NA | NA |
Histopathologic evaluation of one left, central and right sagittal section for each animal at synthetic bone graft (SBG) and control level. Score 0 represent a score of 0 for all sections evaluated within that group. Scores in brackets represent the score of the left, central, and right sagittal section, respectively.
A negative difference is recorded as zero in activity ranking in conclusion.
NA indicates not applicable; SBG, synthetic bone graft.
DISCUSSION
In the present proof-of-concept study, by combining in vivo radiographic CT data and confirmatory ex vivo histologic fusion data in a noninstrumented porcine model of ACDF, a high spinal fusion success rate was demonstrated in the monetite-based SBG group in comparison to the negative control group. The significantly higher fusion rates observed at SBG levels as early as six and nine months postsurgery evaluated by CT are in line with clinical studies investigating cervical interbody fusion using beta-TCPs.31,32 These studies showed successful fusion at six months postsurgery after one-level or two-level discectomy and fusion. However, preclinical porcine lumbar fusion models investigating other bone graft substitutes show a variation in fusion success and time to interbody fusion. Bone marrow mesenchymal stem cells with a low-dose bone morphogenic protein showed a 100% fusion rate as early as three months postsurgery, whereas a tantalum ring with ABG showed a 68.2% fusion rate at six months.33,34 Early bony fusion is desirable, as bony fusion is a key factor in preventing excessive strain on stabilizing implants, which is considered the primary cause of screw loosening or pull-out.35,36 The higher fusion rate seen in the SBG group in the present study was further supported by the tendency toward decreased disc space seen in this group throughout the study period in comparison to the control group. Interestingly, all four SBG fusion masses originated from the intervertebral disc area, starting as an IBF before developing anteriorly to an FbS. In contrast, at the fused control level, the bridging bone originated anteriorly as an FbS and thereafter developed into an IBF. The different areas of fusion origin may be attributed to the capacity of SBG to initiate and augment bone formation.
Both μCT and histopathologic evaluation supported the results of higher fusion success at the SBG levels. In the three μCT specimens analyzed, IBF was confirmed to have a clear trabecular pattern. Histopathologic evaluation confirmed IBF at all four SBG levels and FbS at the one control level. However, histopathologic analysis did not detect IBF at the one-fused control level, whereas CT analysis did. This may be explained by the CT fusion evaluation being more accurate over the entire intervertebral space than the three sections used for histopathology. The finding of more mature bone in SBG fusions than in the one control fusion may indicate that SBG induces earlier bone remodeling and has a resorption rate matching the new bone formation rate, which is an important success factor for SBGs.37,38 However, further studies with longer follow-up periods are needed to evaluate the SBGs final transformation into bone, as aggregates of SBG were still observed at 15 months postsurgery, although no inflammatory cells around the aggregates were observed. Instead, mature bone with a histologic appearance similar to that of native bone was observed next to SBG aggregates, with minimal to moderate amounts of multinucleated giant cells and macrophages with intracellular SBG-like material. This is in line with other studies investigating a similar SBG.25,39 Osteogenic buds consisting of clast-like multinucleated cells and osteoblasts that may represent osteoclastic cutting cones were also observed in the histopathologic analysis. Shah and colleagues discovered that osteoclastic cutting cones play a passive but crucial role in the creation of irregularly shaped CaP islands when they investigated a similar multicomponent CaP formulation 12 months after implantation in an ovine animal model. This suggests a similar mechanism of bone healing and CaP degradation for the material used in the present study, although a more detailed cellular and molecular characterization is necessary to confirm this.
The results of this study need to be considered in light of its limitations. The small sample size limits the ability to detect significant differences in fusion rate as an effect of the SGB. However, according to the American Society for Testing and Materials F2884-21, a sample size of six to eight animals is sufficient for a proof-of-concept. The defect size and amount of SBG used were not standardized, which may have further limited the interpretation of the effect of SBG efficacy on fusion rates. In addition, a positive control comparing SBG to the gold standard ABG would provide important information on the clinical effectiveness of the SBG. Furthermore, the porcine cervical vertebral column differs in morphology and function from the human cervical spine, although it has been shown to be a reasonable surrogate for the human cervical spine.33,34,40
In conclusion, this proof-of-concept study provides preliminary evidence for the favorable performance of this novel Ca-PP-containing and β-TCP-containing monetite SBG as a stand-alone alternative to the negative control level in a clinically relevant porcine model of ACDF. By applying an array of strong assessment methods, including in vivo CT at relevant time points and confirmatory ex vivo histopathology at 15 months postsurgery, a high fusion rate throughout the study period was demonstrated, and high-quality bony fusion was confirmed. These findings support the premise that multicomponent monetite-based bone grafts may be effective bone graft substitutes for ACDF and justify a larger ongoing clinical investigation of these materials for use in spinal fusion.
Key Points
This study preliminarily examined the effectiveness of a calcium pyrophosphate-containing and beta-tricalcium phosphate-containing monetite synthetic bone graft (SBG) in a porcine anterior cervical discectomy and fusion model compared with a negative control.
Complete interbody bony fusion rates at six and nine months were significantly higher in the SBG group than in the negative control group.
At 12-month follow-up, fusion was observed at all SBG levels and at one control level.
High-quality bony fusion was confirmed in the SBG group at 15 months by histopathology.
Supplementary Material
Acknowledgments
The authors thank the study participants; Carola Jansson, Mari Wallbring and Malin Erkas (University Animal Hospital, Swedish University of Agricultural Sciences, Uppsala, Sweden) for their work with the animals on the study; Charles Ley (Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden) for his work on the development of the imaging protocols in the study; and Anneli Rydén and Görel Nyman (Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden) for their work on the anesthetic and care of the animals in the study; Alejandro Lopez (Department of Materials Science and Engineering, Division of Applied Materials Science, Uppsala University, Uppsala, Sweden) for providing the synthetic bone graft and help in producing the material and methods text for the graft; Elin Carlsson (Department of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden) for technical assistance on hard histology samples; Claudia von Brömssen (Department of Energy and Technology, Unit of Applied Statistics and Mathematics, Swedish University of Agricultural Sciences, Uppsala, Sweden) for her consultation on statistics.
Footnotes
O.H. and F.F. contributed equally to this work.
This study was supported by faculty funds (SLU, Swedish University of Agricultural Sciences, Uppsala, Sweden, and a U-Share grant provided by SLU and Uppsala University, Sweden) and Stiftelsen Sällskapsdjurens forskningsfond Ingeborg Ögrens fond, Sweden.
H.E. is a coinventor of patents related to the ceramic material used in the present study. The remaining authors report no conflicts of interest.
Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website: www.spinejournal.com
Contributor Information
Maria Östman, Email: maria.oestman@unibe.ch.
Peter Försth, Email: peter.forsth@uu.se.
Patricia Hedenqvist, Email: patricia.hedenqvist@slu.se.
Håkan Engqvist, Email: hakan.engqvist@angstrom.uu.se.
Leticia Marcelino, Email: leticia.marcelino@slu.se.
Bjørnar Ytrehus, Email: Bjornar.Ytrehus@vetinst.no.
Gry Hulsart-Billström, Email: gry.hulsart_billstrom@mcb.uu.se.
Michael Pujari-Palmer, Email: michael.palmer@slu.se.
Caroline Öhman-Mägi, Email: caroline.ohman@angstrom.uu.se.
Odd Höglund, Email: odd.hoglund@slu.se.
Franck Forterre, Email: franck.forterre@unibe.ch.
References
- 1. Patil PG, Turner DA, Pietrobon R. National trends in surgical procedures for degenerative cervical spine disease: 1990–2000. Neurosurgery. 2005;57:753–758. [PubMed] [Google Scholar]
- 2. Liu CY, Zygourakis CC, Yoon S, et al. Trends in utilization and cost of cervical spine surgery using the National Inpatient Sample Database, 2001 to 2013. Spine (Phila Pa 1976). 2017;42:E906–E913. [DOI] [PubMed] [Google Scholar]
- 3. Cloward RB. The anterior approach for removal of ruptured cervical disks. J Neurosurg. 1958;15:602–617. [DOI] [PubMed] [Google Scholar]
- 4. Smith GW, Robinson RA. The treatment of certain cervical-spine disorders by anterior removal of the intervertebral disc and interbody fusion. J Bone Joint Surg Am. 1958;40-A:607–624. [PubMed] [Google Scholar]
- 5. Pavlov PW. Anterior decompression for cervical spondylotic myelopathy. Eur Spine J. 2003;12(suppl 2):188–194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Saifi C, Fein AW, Cazzulino A, et al. Trends in resource utilization and rate of cervical disc arthroplasty and anterior cervical discectomy and fusion throughout the United States from 2006 to 2013. Spine J. 2018;18:1022–1029. [DOI] [PubMed] [Google Scholar]
- 7. Shriver MF, Lewis DJ, Kshettry VR, Rosenbaum BP, Benzel EC, Mroz TE. Pseudoarthrosis rates in anterior cervical discectomy and fusion: a meta-analysis. Spine J. 2015;15:2016–2027. [DOI] [PubMed] [Google Scholar]
- 8. Zuckerman SL, Devin CJ. Pseudarthrosis of the cervical spine. Clin Spine Surg. 2022;35:97–106. [DOI] [PubMed] [Google Scholar]
- 9. Pennington Z, Mehta VA, Lubelski D, et al. Quality of life and cost implications of pseudarthrosis after anterior cervical discectomy and fusion and its subsequent revision surgery. World Neurosurg. 2020;133:e592–e599. [DOI] [PubMed] [Google Scholar]
- 10. Shousha M, Alhashash M, Allouch H, Boehm H. Reoperation rate after anterior cervical discectomy and fusion using standalone cages in degenerative disease: a study of 2,078 cases. Spine J. 2019;19:2007–2012. [DOI] [PubMed] [Google Scholar]
- 11. Crawford CH, Carreon LY, Mummaneni P, Dryer RF, Glassman SD. Asymptomatic ACDF nonunions underestimate the true prevalence of radiographic pseudarthrosis. Spine (Phila Pa 1976). 2020;45:E776–E780. [DOI] [PubMed] [Google Scholar]
- 12. Wewel JT, Kasliwal MK, Adogwa O, Deutsch H, O’Toole JE, Traynelis VC. Fusion rate following three- and four-level ACDF using allograft and segmental instrumentation: a radiographic study. J Clin Neurosci. 2019;62:142–146. [DOI] [PubMed] [Google Scholar]
- 13. Noordhoek I, Koning MT, Vleggeert-Lankamp CLA. Evaluation of bony fusion after anterior cervical discectomy: a systematic literature review. Eur Spine J. 2019;28:386–399. [DOI] [PubMed] [Google Scholar]
- 14. Carragee EJ, Comer GC, Smith MW. Local bone graft harvesting and volumes in posterolateral lumbar fusion: a technical report. Spine J. 2011;11:540–544. [DOI] [PubMed] [Google Scholar]
- 15. Almaiman M, Al-Bargi HH, Manson P. Complication of anterior iliac bone graft harvesting in 372 adult patients from May 2006 to May 2011 and a literature review. Craniomaxillofac Trauma Reconstr. 2013;6:257–265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Habraken W, Habibovic P, Epple M, Bohner M. Calcium phosphates in biomedical applications: materials for the future? Mater Today. 2016;19:69–87. [Google Scholar]
- 17. Gupta A, Kukkar N, Sharif K, Main BJ, Albers CE, El-Amin SF. Bone graft substitutes for spine fusion: a brief review. World J Orthop. 2015;6:449–456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Ortega B, Gardner C, Roberts S, Chung A, Wang JC, Buser Z. Ceramic biologics for bony fusion—a journey from first to third generations. Curr Rev Musculoskelet Med. 2020;13:530–536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Frohlich M, Grayson W, Wan L, Marolt D, Drobnic M, Vunjak- Novakovic G. Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther. 2008;3:254–264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Engstrand J, Aberg J, Engqvist H. Influence of water content on hardening and handling of a premixed calcium phosphate cement. Mater Sci Eng C. 2013;33:527–531. [DOI] [PubMed] [Google Scholar]
- 21. Yu Y, Guo H, Pujari-Palmer M, et al. Advanced solid-state 1H/31P NMR characterization of pyrophosphate-doped calcium phosphate cements for biomedical applications: the structural role of pyrophosphate. Ceram Int. 2019;45:20642–20655. [Google Scholar]
- 22. Montazerolghaem M, Karlsson Ott M, Engqvist H, Melhus H, Rasmusson AJ. Resorption of monetite calcium phosphate cement by mouse bone marrow derived osteoclasts. Mater Sci Eng C. 2015;52:212–218. [DOI] [PubMed] [Google Scholar]
- 23. Suchanek K, Bartkowiak A, Perzanowski M, Marszałek M. From monetite plate to hydroxyapatite nanofibers by monoethanolamine assisted hydrothermal approach. Sci Rep. 2018;8:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Omar O, Engstrand T, Kihlström Burenstam Linder L, et al. In situ bone regeneration of large cranial defects using synthetic ceramic implants with a tailored composition and design. Proc Natl Acad Sci. 2020;117:26660–26671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Gallinetti S, Linder LKB, Åberg J, Illies C, Engqvist H, Birgersson U. Titanium reinforced calcium phosphate improves bone formation and osteointegration in ovine calvaria defects: a comparative 52 weeks study. Biomed Mater. 2021;16. doi: 10.1088/1748-605X/abca12 [DOI] [PubMed] [Google Scholar]
- 26. Engstrand T, Kihlström L, Neovius E, et al. Development of a bioactive implant for repair and potential healing of cranial defects: Technical note. J Neurosurg. 2014;120:273–277. [DOI] [PubMed] [Google Scholar]
- 27. Engstrand T, Kihlström L, Lundgren K, Trobos M, Engqvist H, Thomsen P. Bioceramic implant induces bone healing of cranial defects. Plast Reconstr Surg Glob Open. 2015;3:1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Best NNA Grundl M Anv LS, et al. Statens jordbruksverks författningssamling. 2011.
- 29. Horos software v3.3.6. 2020, Horos Project, Nimble Co LLC d/b/a Purview in Annapolis MU, USA. https://horosproject.org
- 30. ISO 10993-6, Biological evaluation of medical devices—Part 6: tests for local effects after implantation, Vernier, Geneva, Switzerland.
- 31. Dai LY, Jiang LS. Anterior cervical fusion with interbody cage containing β-tricalcium phosphate augmented with plate fixation: a prospective randomized study with 2-year follow-up. Eur Spine J. 2008;17:698–705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Sugawara T, Itoh Y, Hirano Y, Higashiyama N, Mizoi K. Β-tricalcium phosphate promotes bony fusion after anterior cervical discectomy and fusion using titanium cages. Spine (Phila Pa 1976). 2011;36:1509–1514. [DOI] [PubMed] [Google Scholar]
- 33. Hu T, Liu L, Lam RWM, et al. Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold-based spinal fusion in a porcine model. J Tissue Eng Regen Med. 2022;16:63–75. [DOI] [PubMed] [Google Scholar]
- 34. Wilke HJ, Geppert J, Kienle A. Biomechanical in vitro evaluation of the complete porcine spine in comparison with data of the human spine. Eur Spine J. 2011;20:1859–1868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Wu X, Shi J, Wu J, et al. Pedicle screw loosening: the value of radiological imagings and the identification of risk factors assessed by extraction torque during screw removal surgery. J Orthop Surg Res. 2019;14:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Dhar UK, Menzer EL, Lin M, et al. Factors influencing cage subsidence in anterior cervical corpectomy and discectomy: a systematic review. Eur Spine J. 2023;32:957–968. [DOI] [PubMed] [Google Scholar]
- 37. Lee JH, Ryu HS, Seo JH, Lee DY, Chang BS, Lee CK. Negative effect of rapidly resorbing properties of bioactive glass-ceramics as bone graft substitute in a rabbit lumbar fusion model. Clin Orthop Surg. 2014;6:87–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Chu TM, Orton DG, Hollister SJ, Feinberg SE, Halloran JW. Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures. Biomaterials. 2002;23:1283–1293. [DOI] [PubMed] [Google Scholar]
- 39. Trbakovic A, Hedenqvist P, Mellgren T, et al. A new synthetic granular calcium phosphate compound induces new bone in a sinus lift rabbit model. J Dent. 2018;70:31–39. [DOI] [PubMed] [Google Scholar]
- 40. Zhou Z, Wei F, Huang S, et al. In vivo magnetic resonance imaging evaluation of porous tantalum interbody fusion devices in a porcine spinal arthrodesis model. Spine (Phila Pa 1976). 2015;40:1471–1478. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
